Edition:
United States

Acura Pharmaceuticals Inc (ACUR.O)

ACUR.O on Consolidated Issue listed on NASDAQ Capital Market

1.00USD
9 Dec 2016
Change (% chg)

$0.09 (+9.30%)
Prev Close
$0.92
Open
$0.94
Day's High
$1.19
Day's Low
$0.92
Volume
1,038,920
Avg. Vol
51,009
52-wk High
$3.52
52-wk Low
$0.85

ACUR.O

Chart for ACUR.O

About

Acura Pharmaceuticals, Inc. is a pharmaceutical company. The Company is engaged in the research, development and commercialization of technologies and products intended to address medication abuse and misuse. The Company has discovered and developed three platform technologies, which can be used to develop multiple products. The... (more)

Overall

Beta: 2.14
Market Cap(Mil.): $11.83
Shares Outstanding(Mil.): 11.83
Dividend: --
Yield (%): --

Financials

  ACUR.O Industry Sector
P/E (TTM): -- 41.98 30.40
EPS (TTM): -0.83 -- --
ROI: -105.56 -0.36 15.24
ROE: -238.90 -0.94 16.58

BRIEF-Acura Pharmaceuticals qtrly loss per share $0.19

* Acura Pharmaceuticals announces third quarter 2016 financial results

Nov 14 2016

BRIEF-KemPharm announces licensing agreement with Acura

* KemPharm announces licensing agreement with Acura Pharmaceuticals for aversion abuse-deterrent technology

Oct 18 2016

BRIEF-Acura Pharmaceuticals qtrly loss per share $0.28

* Acura pharmaceuticals inc says revenues for quarter were $257 thousand compared to $341 thousand in q2 of 2015

Aug 08 2016

Earnings vs. Estimates